Efficacy and safety of sacubitril/valsartan compared with enalapril in patients with chronic heart failure and reduced ejection fraction: Results from PARADIGM-HF India sub-study
CONCLUSION: Results support the use of sacubitril/valsartan in Indian patients with chronic HF with reduced ejection fraction with treatment benefits similar to global PARADIGM-HF cohort.PMID:33357641 | PMC:PMC7772612 | DOI:10.1016/j.ihj.2020.09.016
Source: Indian Heart J - Category: Cardiology Authors: Anil Ranjeetmal Jain Rakesh Kumar Aggarwal Nanyam Srinivas Rao Gauri Billa Shankar Kumar Source Type: research
More News: Cardiology | Cardiovascular | Diovan | Enalapril | Heart | Heart Failure | India Health | Study